Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene

Circulation. 1997 Nov 18;96(10):3570-8. doi: 10.1161/01.cir.96.10.3570.

Abstract

Background: To evaluate the role of kinins in the regulation of cardiovascular function, we studied the phenotype of a mouse strain with disruption of the bradykinin B2-receptor gene (Bk 2r-/-).

Methods and results: Under basal conditions, tail-cuff blood pressure was higher in Bk2r-/- than in wild-type Bk2r+/+ and heterozygous Bk2r+/- mice (124+/-1 versus 109+/-1 and 111+/-2 mm Hg, respectively; P<.01 for both comparisons), a difference that was confirmed by measurements of intra-arterial blood pressure in unanesthetized mice. Heart weight was greater in Bk2r-/- than in Bk2r+/+ and Bk2r+/- mice (505+/-10 versus 449+/-12 and 477+/-10 mg/100 g body wt, P<.05). Chronic blockade of B2-receptors by Icatibant (50 nmol/100 g body wt twice a day S.C.) or inhibition of nitric oxide synthase by nitro-L-arginine-methyl ester (0.14 mmol/100 g body wt orally) increased the blood pressure of Bk2r+/+ to the levels of Bk2r-/- mice. Compared with the wild-type strain, both Bk2r-/- and Bk2r+/- mice showed exaggerated vasopressor responses to angiotensin II. In addition, chronic administration of an angiotensin AT1-receptor antagonist reduced the basal blood pressure of Bk2r-/- by 21+/-3 mmHg (P<.05) to the levels of Bk2r+/+. No difference was detected between strains as far as plasma renin activity and the expression of renin and AT1-receptor genes are concerned. Chronic salt loading (0.84 mmol/g chow for 15 days) increased the blood pressure of Bk2r-/- and Bk2r+/- by 34+/-3 and 14+/-6 mm Hg, respectively, whereas it was ineffective in Bk2r+/+.

Conclusions: Our results suggest that a normally functioning B2-receptor is essential for the maintenance of cardiovascular homeostasis in mice. Dysfunction of the kallikrein-kinin system could contribute to increase blood pressure levels by leaving the activity of vasoconstrictor agents unbalanced.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Angiotensin Receptor Antagonists
  • Animals
  • Antihypertensive Agents / pharmacology
  • Blood Pressure / drug effects
  • Bradykinin Receptor Antagonists
  • Cardiovascular Physiological Phenomena*
  • Diet, Sodium-Restricted
  • Enzyme Inhibitors / pharmacology
  • Kidney / metabolism
  • Mice / genetics*
  • Myocardium / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nicotinic Acids / pharmacology
  • Phenotype
  • RNA, Messenger / metabolism
  • Receptors, Angiotensin / genetics
  • Receptors, Bradykinin / agonists
  • Receptors, Bradykinin / genetics*
  • Renin / genetics
  • Species Specificity
  • Tetrazoles / pharmacology

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Bradykinin Receptor Antagonists
  • Enzyme Inhibitors
  • Nicotinic Acids
  • RNA, Messenger
  • Receptors, Angiotensin
  • Receptors, Bradykinin
  • Tetrazoles
  • Angiotensin II
  • A 81988
  • Renin
  • NG-Nitroarginine Methyl Ester